Navigation Links
Ferring Pharmaceuticals Provides Baby Quest Foundation Grant Recipients with Free Access to Fertility Medication
Date:8/20/2013

PARSIPPANY, N.J., Aug. 20, 2013 /PRNewswire-USNewswire/ -- In a continued effort to support patients facing infertility, Ferring Pharmaceuticals Inc. today announced a donation to Baby Quest Foundation, Inc. – a non-profit organization focused on providing financial assistance to patients pursuing fertility treatment. Through this collaboration, Ferring will provide 10 Baby Quest grant recipients with free access to select fertility medications, enabling them to undergo one full IVF cycle, with the hopes of helping them achieve their dream of parenthood.

(Photo: http://photos.prnewswire.com/prnh/20130820/DC66400)

It is estimated that about 6.7 million women between the ages of 15 to 44 in the U.S. experience infertility or the inability to carry a baby to term. [i]

"Each year, millions of families struggle with getting pregnant," said Justin Rauschkolb, Manager of Product Promotions of Ferring's reproductive health unit.  "Through our work with Baby Quest, we aspire to help some of these patients build and grow their families, while also providing hope for others still on the journey to becoming parents."

Ferring and Baby Quest kicked off their partnership at NASDAQ, where Baby Quest co-founder Pamela Hirsch and team rang the opening bell.  

"We are so thankful for the generosity of Ferring Pharmaceuticals in donating medication so that our grant recipients can pursue infertility treatment," said Hirsch.  "Their donation allows us to continue our work of increasing public awareness of the condition of infertility and of providing financial assistance to those who cannot afford the high costs of fertility treatments."

Ferring, as a company, has a commitment to helping patients realize their dream of parenthood. In addition to their work with Baby Quest, Ferring has other initiatives supporting both patients facing infertility and the community including:

  • Heart Beat Patient Assistance Program – Offers financial assistance for eligible patients pursuing fertility preservation services prior to cancer treatment. For more information, visit www.ferringfertility.com/savings/heartbeat.
  • 2013 Heart to Heart Video Contest – Allows participants the chance to win up to $15,000 toward their child's education for submitting a video essay telling the story of their steps on the path to parenthood. For more information or to submit a video by the August 31st deadline, visit www.hearttoheartcontest.com.
  • Local Playground Adoption – The Reproductive Health Unit of Ferring's Parsippany office adopted a local playground as a part of the Morristown "Adopt-a-Spot" program and Ferring's "Living the Philosophy" initiative, which grants employees one day per quarter to dedicate to service. Ferring will be responsible for upkeep of the park throughout the year. For more information about Ferring's community involvement, visit www.ferringusa.com/about/community

To learn more about Ferring's initiatives in reproductive health, visit www.ferringfertility.com.

About Ferring Pharmaceuticals Inc.

Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of reproductive health, urologygastroenterologyendocrinology and osteoarthritis. For more information, visit www.ferringUSA.com.


[i]"Infertility." Centers for Disease Control and Prevention. 2013. http://www.cdc.gov/nchs/fastats/fertile.htm.


'/>"/>
SOURCE Ferring Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ferring Pharmaceuticals Inc. Announces $1M Donation to the Alliance for Fertility Preservation, a Newly Formed Charitable Organization
2. Ferring Pharmaceuticals Extends Its Heart to Heart Video Contest
3. Ferring Pharmaceuticals Inc. Adopts Local Morristown Playground
4. Ferring Announces It Will Present Phase 3 Data for Cervical Ripening Agent at American College of Obstetricians and Gynecologists Annual Clinical Meeting
5. Ferring to Highlight Phase 3 Data for Cervical Ripening Candidate at Society for Maternal-Fetal Medicine Annual Meeting
6. Ferring Pharmaceuticals Inc. Recognized for Best-in-Class Work-Life Portfolio
7. Ferring Pharmaceuticals Inc. Named 10th Fastest Growing New Jersey Company
8. ESTEVE Fosters R & D by Transferring its Center for Drug Discovery to the Science Park of Barcelona (PCB)
9. Johnson & Johnson Completes Acquisition Of Aragon Pharmaceuticals, Inc.
10. HedgePath Pharmaceuticals, Inc. Completes Reorganization Plan with Commonwealth Biotechnologies
11. TetraLogic Pharmaceuticals Announces New Executives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)...   TyrNovo , s NT219 ... cancer drug resistance and would ...   NT219 is a novel proprietary ... oncogenic pathways ( IRS1/2 and STAT3) highly ... the tumor .   NT219 has ...
(Date:1/12/2017)... 2017 This new report from VPGMarketResearch contains ... of the German hospital microbiology testing market, including:  ... hospital laboratory practice, as well as key economic, regulatory, ... during the next ten years.  ... and etiology of major infectious diseases and microorganisms.  ...
(Date:1/12/2017)... -- Harrington Discovery Institute at University Hospitals in ... Drug Discovery Foundation (ADDF) have expanded their collaboration ... Alzheimer,s disease. Together, the two organizations will jointly ... academic researchers. By leveraging their combined expertise, investment, ... will advance Alzheimer,s disease drug discovery projects of ...
Breaking Medicine Technology:
(Date:1/13/2017)... ... January 13, 2017 , ... The 18th European Congress: Perspectives in Lung Cancer ... 2017. This Congress is expertly designed to meet the educational needs of European ... cancer. , Chaired by Dr. Giorgio V. Scagliotti, Professor of Oncology at the University ...
(Date:1/13/2017)... ... January 13, 2017 , ... KOAMTAC ®, Inc., a leading ... the next generation companion scanner and data collector at the National Retail Federation’s Big ... created as an answer to the market’s need for more compact and rugged devices ...
(Date:1/13/2017)... ... ... inventor from Pahrump, Nev., used an unsavory medical experience to think of a way to ... urine bag for a half year due to lazy bladder," he said. "Keeping these things ... better way to do this." , He then designed and created a prototype of the ...
(Date:1/13/2017)... ... ... People who have sensitive teeth are about as common as those who do ... dental hygiene products in the market contain chemical ingredients that only aggravate the condition ... oral care routine to keep their teeth white and healthy is a struggle with ...
(Date:1/13/2017)... Okla. (PRWEB) , ... January 13, 2017 , ... Friday, ... the area of the game room, increasing the size of the location to 90,000 ... Course, an 8-hole mini golf course that takes customers on an educational tour of ...
Breaking Medicine News(10 mins):